Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 16.89B
March 31, 2026 16.86B
December 31, 2025 17.43B
September 30, 2025 16.89B
June 30, 2025 16.03B
March 31, 2025 14.84B
December 31, 2024 16.89B
September 30, 2024 18.65B
June 30, 2024 18.54B
March 31, 2024 9.695B
December 31, 2023 12.88B
September 30, 2023 14.29B
June 30, 2023 15.46B
Date Value
March 31, 2023 13.19B
December 31, 2022 14.81B
September 30, 2022 13.15B
June 30, 2022 9.759B
March 31, 2022 6.858B
December 31, 2021 1.925B
September 30, 2021 2.773B
June 30, 2021 1.084B
March 31, 2021 1.048B
December 31, 2020 1.481B
September 30, 2020 1.161B
June 30, 2020 643.58M
March 31, 2020 495.51M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Moderna, Inc. 5.138B
Biodexa Pharmaceuticals Plc --
NuCana Plc 25.89M
Mereo BioPharma Group Plc 30.12M
MediGene AG --